Bupa rolls out genomics-led prevention pathways

Bupa has launched a genomics-led preventive care offering for its UK insurance customers, targeting breast cancer, cardiovascular disease and diabetes. The new ‘Prevention Pathways’ will use clinical assessments including genetic risk to guide access to diagnostics, specialist support and, in some cases, preventive treatment. Bupa expects more than 200,000 customers to use the pathways by…